SCHEMBL13870957

SCHEMBL13870957

CCc1cc2ccc(-c3ccc(C)cc3C)nc2cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.41
NPSR1 Q6W5P4 3/20 0.41
TLR8 Q9NR97 1/20 0.38
ALPL P05186 2/20 0.38
CA9 Q16790 1/20 0.38
MAPT P10636 4/20 0.37
RXFP1 Q9HBX9 1/20 0.37
ALDH1A1 P00352 6/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36
CYP1A2 P05177 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 2/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ESR1 P03372 1/20 0.35
TSHR P16473 2/20 0.34
ALOX15 P16050 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
AR P10275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870959 0.88 KMT2A (0.43) KMT2ANPSR1TLR8MAPTRXFP1
SCHEMBL13870958 0.85 NQO2 (0.35) KMT2ANPSR1MAPTALDH1A1MEN1
SCHEMBL13870906 0.84 CYP1A2 (0.41) KMT2ANPSR1TLR8ALPLCA9
SCHEMBL16487811 0.83 KMT2A (0.39) KMT2ANPSR1TLR8ALPLCA9
SCHEMBL13989405 0.81 CYP1A2 (0.53) KMT2ANPSR1TLR8ALPLCA9
SCHEMBL13298969 0.79 CYP1A2 (0.55) KMT2ANPSR1TLR8ALPLCA9
SCHEMBL13870949 0.79 KMT2A (0.36) KMT2ANPSR1MAPTRXFP1ALDH1A1
SCHEMBL13870948 0.78 KMO (0.42) KMT2ANPSR1TLR8MAPTALDH1A1
SCHEMBL13870956 0.78 NUDT1 (0.39) KMT2ATLR8MAPTALDH1A1MEN1
SCHEMBL13870937 0.76 PDGFRB (0.47) NPSR1ALPLMAPTRXFP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 KMT2A 2208/4885NPSR1 3158/4885TLR8 4593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.